Return to site

Rat Model Market Report Analysed by Size, Share, Growth, Industry Demand and Forecast

The Global Rat Model Market is expected to reach $588.9 Million, growing at a CAGR of 8.7%

According to the new market research report Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

The global rat model market is segmented on the basis of model type, service, therapeutic area, technology, end user, care product, and region.

On the basis of model type, the market is categorized into outbred rat, inbred rats, knockout/genetically modified rats, conditioned/surgically modified rats, hybrid/congenic rats, and immunodeficient rats. In 2016, the outbred rats segment is estimated to account for the largest share of the global rat model market.

Rat Model Market

Browse and in-depth TOC on “Rat Model Market

132 — Tables

47 — Figures

253 — Pages

On the basis of technology, the market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (genetically modified sperm-mediated gene transfer, virus/vector mediated gene transfer, liposome-mediated DNA & electroporation of DNA, biolistics, and TALENs & ZFN). In 2016, the CRISPR segment is expected to command the largest share of the global rat model market.

On the basis of end user, the rat model market is segmented into pharmaceutical & biotechnology companies, academic & research institutions, and contract research organizations (CROs). In 2016, the pharmaceutical & biotechnology companies segment is expected to command the largest share of the global rat model market.

Charles River Laboratories International, Inc. (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), Biomere (U.S.), Janvier Labs (France), genOway SA (France), and Horizon Discovery Group plc (U.K.) are some of the key players in the rat model market worldwide.